Sargent Bickham Lagudis LLC Abb Vie Inc. Transaction History

Sargent Bickham Lagudis LLC

$1.22 Billion
Q4 2022

A detailed history of Sargent Bickham Lagudis LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 24,242 shares of ABBV stock, worth $4.29 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

24,242

Previous 24,215 0.11%

Holding current value

$4.29 Million

Previous $3.25 Million 20.62%

% of portfolio

0.32%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $3,734 - $4,478	27 Added 0.11%	24,242 $0
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $20,265 - $23,243	-151 Reduced 0.62%	24,215 $3.25 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $298,910 - $380,013	-2,172 Reduced 8.18%	24,366 $3.73 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $20,192 - $25,053	-153 Reduced 0.57%	26,538 $4.3 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $13,858 - $17,534	129 Added 0.49%	26,691 $3.61 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $409,214 - $464,519	3,846 Added 16.93%	26,562 $2.87 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $23,146 - $25,786	-220 Reduced 0.96%	22,716 $2.56 Million
Q1 2021 May 24, 2021	SELL	$102.3 - $112.62 $2,250 - $2,477	-22 Reduced 0.1%	22,936 $2.48 Million
Q4 2020 May 24, 2021	BUY	$80.49 - $108.67 $1,770 - $2,390	22 Added 0.1%	22,958 $2.46 Million
Q4 2020 May 24, 2021	BUY	$80.49 - $108.67 $8,129 - $10,975	101 Added 0.44%	22,936 $2.48 Million
Q3 2020 Sep 01, 2021	BUY	$85.91 - $100.83 $40,205 - $47,188	468 Added 2.09%	22,835 $2 Million
Q2 2020 Sep 07, 2021	SELL	$73.37 - $98.18 $78,432 - $104,954	-1,069 Reduced 4.56%	22,367 $2.2 Million
Q1 2020 Sep 07, 2021	BUY	$64.5 - $97.79 $155,122 - $235,184	2,405 Added 11.44%	23,436 $1.79 Million
Q4 2019 Sep 14, 2021	SELL	$72.13 - $90.25 $16,950 - $21,208	-235 Reduced 1.11%	21,031 $1.86 Million
Q3 2019 Sep 14, 2021	SELL	$62.98 - $75.72 $2,204 - $2,650	-35 Reduced 0.16%	21,266 $1.61 Million
Q2 2019 Sep 13, 2021	SELL	$65.7 - $83.98 $36,923 - $47,196	-562 Reduced 2.57%	21,301 $1.55 Million
Q1 2019 Sep 13, 2021	SELL	$77.14 - $90.79 $1.97 Million - $2.31 Million	-25,484 Reduced 53.82%	21,863 $1.76 Million
Q4 2018 Sep 13, 2021	BUY	$77.85 - $96.01 $81,820 - $100,906	1,051 Added 2.27%	47,347 $4.37 Million
Q3 2018 Sep 13, 2021	SELL	$88.91 - $98.84 $2,044 - $2,273	-23 Reduced 0.05%	46,296 $4.38 Million
Q2 2018 Sep 13, 2021	BUY	$89.78 - $106.23 $114,110 - $135,018	1,271 Added 2.82%	46,319 $4.29 Million
Q1 2018 Sep 13, 2021	SELL	$92.01 - $123.21 $88,697 - $118,774	-964 Reduced 2.1%	45,048 $4.26 Million
Q4 2017 Sep 13, 2021	BUY	$89.56 - $98.21 $113,203 - $124,137	1,264 Added 2.82%	46,012 $4.45 Million
Q3 2017 Sep 13, 2021	BUY	$69.85 - $89.22 $134,251 - $171,480	1,922 Added 4.49%	44,748 $3.98 Million
Q2 2017 Sep 13, 2021	SELL	N/A	-6,049 Reduced 12.38%	42,826 $3.11 Million
Q1 2017 Sep 13, 2021	SELL	N/A	-15,254 Reduced 23.79%	48,875 $3.19 Million
Q4 2016 Sep 13, 2021	BUY	N/A	63,318 Added 7807.4%	64,129 $4.02 Million
Q3 2016 Sep 13, 2021	SELL	N/A	-68,079 Reduced 98.82%	811 $4.44 Million
Q2 2016 Sep 07, 2021	SELL	N/A	-2,895 Reduced 4.03%	68,890 $4.27 Million
Q1 2016 Sep 07, 2021	BUY	N/A	71,785	71,785 $4.1 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Account

Sargent Bickham Lagudis LLC Abb Vie Inc. Transaction History